zoledronic acid has been researched along with Neoplasms, Bronchial in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Eppard, E; Essler, M; Kürpig, S; Meisenheimer, M | 1 |
| Bartl, R | 1 |
2 other study(ies) available for zoledronic acid and Neoplasms, Bronchial
| Article | Year |
|---|---|
DOTA-ZOL: A Promising Tool in Diagnosis and Palliative Therapy of Bone Metastasis-Challenges and Critical Points in Implementation into Clinical Routine.
Topics: Bone Density Conservation Agents; Bone Neoplasms; Bronchial Neoplasms; Gallium Radioisotopes; Heterocyclic Compounds, 1-Ring; Humans; Isotope Labeling; Palliative Care; Quality Control; Radiopharmaceuticals; Zoledronic Acid | 2020 |
[Bisphosphonates for osseus invasion caused by bronchial carcinoma].
Topics: Administration, Oral; Bone Density Conservation Agents; Bone Neoplasms; Bronchial Neoplasms; Clodronic Acid; Diphosphonates; Female; Humans; Ibandronic Acid; Imidazoles; Injections, Intravenous; Osteoporosis; Zoledronic Acid | 2008 |